FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025373757> ?p ?o ?g. }

• W3025373757 endingPage "11" @default.
• W3025373757 startingPage "1" @default.
• W3025373757 abstract "Soft tissue sarcomas (STS) are a highly aggressive and heterogeneous group of malignant mesenchymal tumors. The prognosis of patients with advanced or metastatic STS remains poor, and the main therapy of STS patients combines primary surgery, radiotherapy, and chemotherapy. Aberrant DNA methylation shows close association with the pathogenesis and tumor progression. Therefore, DNA methylation biomarkers might have the potential in accurately predicting the survival of STS patients. In order to identify a prognostic biomarker based on DNA methylation sites, a comprehensive analysis of the DNA methylation profile of STS patients in the Cancer Genome Atlas (TCGA) database was performed. All samples were randomly divided into training and testing datasets. Cox proportional hazards regression analysis was performed to identify a prognostic biomarker that contains three DNA methylation sites. The Kaplan–Meier analysis demonstrated that the 3-DNA methylation biomarker discriminated patients into high-risk and low-risk groups, both in the training and in the testing datasets, and the area under the receiver operating characteristic curve values (AUCs) were 0.844 (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M1><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn>0.001</mml:mn></mml:math>, 95% CI: 0.740–0.948) and 0.710 (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M2><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mn>0.002</mml:mn></mml:math>, 95% CI: 0.595–0.823), respectively. Besides, this biomarker presented superior prognostic performance in STS patients with different age, sex, tissue of origin, therapy, and histologic subtypes. Compared with other prognostic biomarkers, this biomarker tended to be a more precise prognostic factor in STS patients. Moreover, methylation sites in this biomarker might provide a new way for clinicians to make decisions regarding the intervention and assess the effectiveness of an individual therapeutic strategy." @default.
• W3025373757 created "2020-05-21" @default.
• W3025373757 creator A5012718640 @default.
• W3025373757 creator A5020871102 @default.
• W3025373757 creator A5030797755 @default.
• W3025373757 creator A5045797431 @default.
• W3025373757 creator A5049596129 @default.
• W3025373757 creator A5052677267 @default.
• W3025373757 creator A5065763596 @default.
• W3025373757 date "2020-05-15" @default.
• W3025373757 modified "2023-10-01" @default.
• W3025373757 title "Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma" @default.
• W3025373757 cites W1494988280 @default.
• W3025373757 cites W1586730439 @default.
• W3025373757 cites W1606664976 @default.
• W3025373757 cites W1831033366 @default.
• W3025373757 cites W1965262464 @default.
• W3025373757 cites W1976673922 @default.
• W3025373757 cites W1986083764 @default.
• W3025373757 cites W199581144 @default.
• W3025373757 cites W1998390679 @default.
• W3025373757 cites W2018153447 @default.
• W3025373757 cites W2020617188 @default.
• W3025373757 cites W2020902746 @default.
• W3025373757 cites W2025181290 @default.
• W3025373757 cites W2035505168 @default.
• W3025373757 cites W2072576191 @default.
• W3025373757 cites W2155893315 @default.
• W3025373757 cites W2314685854 @default.
• W3025373757 cites W2516868930 @default.
• W3025373757 cites W2543795704 @default.
• W3025373757 cites W2551773592 @default.
• W3025373757 cites W2561057953 @default.
• W3025373757 cites W2613940750 @default.
• W3025373757 cites W2738027807 @default.
• W3025373757 cites W2789727733 @default.
• W3025373757 cites W2810321039 @default.
• W3025373757 cites W2889291178 @default.
• W3025373757 cites W2897019055 @default.
• W3025373757 cites W2902411554 @default.
• W3025373757 cites W2911188335 @default.
• W3025373757 cites W2914175608 @default.
• W3025373757 cites W2947586730 @default.
• W3025373757 cites W2997882698 @default.
• W3025373757 cites W2221958973 @default.
• W3025373757 doi "https://doi.org/10.1155/2020/8106212" @default.
• W3025373757 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7245661" @default.
• W3025373757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32508922" @default.
• W3025373757 hasPublicationYear "2020" @default.
• W3025373757 type Work @default.
• W3025373757 sameAs 3025373757 @default.
• W3025373757 citedByCount "2" @default.
• W3025373757 countsByYear W30253737572021 @default.
• W3025373757 crossrefType "journal-article" @default.
• W3025373757 hasAuthorship W3025373757A5012718640 @default.
• W3025373757 hasAuthorship W3025373757A5020871102 @default.
• W3025373757 hasAuthorship W3025373757A5030797755 @default.
• W3025373757 hasAuthorship W3025373757A5045797431 @default.
• W3025373757 hasAuthorship W3025373757A5049596129 @default.
• W3025373757 hasAuthorship W3025373757A5052677267 @default.
• W3025373757 hasAuthorship W3025373757A5065763596 @default.
• W3025373757 hasBestOaLocation W30253737571 @default.
• W3025373757 hasConcept C104317684 @default.
• W3025373757 hasConcept C126322002 @default.
• W3025373757 hasConcept C143998085 @default.
• W3025373757 hasConcept C150194340 @default.
• W3025373757 hasConcept C190727270 @default.
• W3025373757 hasConcept C2781197716 @default.
• W3025373757 hasConcept C33288867 @default.
• W3025373757 hasConcept C50382708 @default.
• W3025373757 hasConcept C54355233 @default.
• W3025373757 hasConcept C552990157 @default.
• W3025373757 hasConcept C58471807 @default.
• W3025373757 hasConcept C60644358 @default.
• W3025373757 hasConcept C71924100 @default.
• W3025373757 hasConcept C86803240 @default.
• W3025373757 hasConceptScore W3025373757C104317684 @default.
• W3025373757 hasConceptScore W3025373757C126322002 @default.
• W3025373757 hasConceptScore W3025373757C143998085 @default.
• W3025373757 hasConceptScore W3025373757C150194340 @default.
• W3025373757 hasConceptScore W3025373757C190727270 @default.
• W3025373757 hasConceptScore W3025373757C2781197716 @default.
• W3025373757 hasConceptScore W3025373757C33288867 @default.
• W3025373757 hasConceptScore W3025373757C50382708 @default.
• W3025373757 hasConceptScore W3025373757C54355233 @default.
• W3025373757 hasConceptScore W3025373757C552990157 @default.
• W3025373757 hasConceptScore W3025373757C58471807 @default.
• W3025373757 hasConceptScore W3025373757C60644358 @default.
• W3025373757 hasConceptScore W3025373757C71924100 @default.
• W3025373757 hasConceptScore W3025373757C86803240 @default.
• W3025373757 hasFunder F4320325553 @default.
• W3025373757 hasLocation W30253737571 @default.
• W3025373757 hasLocation W30253737572 @default.
• W3025373757 hasLocation W30253737573 @default.
• W3025373757 hasLocation W30253737574 @default.
• W3025373757 hasOpenAccess W3025373757 @default.
• W3025373757 hasPrimaryLocation W30253737571 @default.
• W3025373757 hasRelatedWork W1698395555 @default.

• next